Home/Filings/4/0001209191-17-047087
4//SEC Filing

Randall Lorin 4

Accession 0001209191-17-047087

CIK 0001008848other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 4:05 PM ET

Size

8.9 KB

Accession

0001209191-17-047087

Insider Transaction Report

Form 4
Period: 2017-07-31
Transactions
  • Sale

    Common Stock

    2017-07-31$21.66/sh10,000$216,6150 total
  • Exercise/Conversion

    Common Stock

    2017-07-31$18.21/sh+10,000$182,10010,000 total
  • Exercise/Conversion

    Non-Employee Stock Option

    2017-07-3110,0000 total
    Exercise: $18.21Exp: 2017-08-06Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]The exercised options were scheduled to expire in 2017 on the expiration date reported within Table II unless exercised.
  • [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $21.6500 to $21.7010 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]The shares subject to these options vested in installments and were fully vested on June 5, 2008.

Issuer

ACORDA THERAPEUTICS INC

CIK 0001008848

Entity typeother

Related Parties

1
  • filerCIK 0001352452

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:05 PM ET
Size
8.9 KB